Previous Page  40 / 63 Next Page
Information
Show Menu
Previous Page 40 / 63 Next Page
Page Background

Ongoing trials modulating the stroma

• The stroma can block the penetration of

chemotherapeutic agents and facilitate

immune escape.

FAK

is a tyrosine kinase expressed in PDAC

cells and stroma that produces stromal

fibrosis.

Agent

Target Combined with Phase N

NCT

Defactinib FAK Pembrolizumab I/IIA 59* NCT02758587

VS-4718

FAK

Gem/nab

I

13 NCT02651727

Defactinib FAK Gem + pembro

I

50* NCT02546531

Jiang H, et al.

Nature Med.

2016

* Includes other cancers also